Clinical Trial Update: Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for EchoCRT (echocardiography-guided cardiac resynchronization therapy) shows termination after Phase 2/3 with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ventricular Dyssynchrony

Drugs mentioned

• EchoCRT

Snippet

Sponsor: Biotronik, Inc. | Conditions: Heart Failure, Ventricular Dyssynchrony | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2014-04-17